MESUAFERRIN A-BIOACTIVE FLAVONOID ISOLATED FROM THE BARK OF MESUA FERREA L. AGAINST PHOSPHOLIPASE A2, CYCLOOXYGENASE AND LIPOXYGENASE: AN IN VITRO, IN VIVO AND IN SILICO APPROACH
Objective: The main objective of the present study was to evaluate the anti-inflammatory activity of isolated bioactive flavonoid Mesuaferrin-A from the bark of Mesuaferrea L. by in vitro, in vivo and in silico approach.
Methods: To evaluate the effect of isolated bioactive flavonoid Mesuaferrin-A on arachidonic acid metabolizing enzymes (PLA2, COX-2 and 5-LOX) using in vitro methods, followed by carrageenan-induced paw edema model by in vivo and to determine the binding orientation and interactions of Mesuaferrin-A onarachidonic acid metabolizing enzymes (PLA2, COX-2 and 5-LOX) crystal proteins using molecular docking (in silico) studies.
Results: Mesuaferrin-A exhibited a dose-dependent significant 5-LOX inhibitory and considerable COX-2 inhibitory activity by in vitro, The inhibitory activities of 5-LOX and COX-2 at 100Âµg/ml were found to be 78.67%, 81.03% with IC50 values of 45.22Âµg/ml and 35.74Âµg/ml respectively. Whereas Mesuaferrin-A showed less PLA2 inhibitory activity. Mesuaferrin-A showed 68.34% inhibitory activity at 400 mg/kg body weight at the late phase of carrageenan-induced paw edema, and In silico studies demonstrated that Mesuaferrin-A strongly binds with 5-LOX and COX-2, these strong binding affinity of Mesuaferrin-A on active site amino acids of 5-LOX and COX-2 may be responsible for inhibition of enzyme activity. Mesuaferrin-A showeda comparable 5-LOX and COX-2 inhibition activity with (positive control).
Conclusion: It was concluded that Mesuaferrin-A act as 5-LOX and COX dual inhibitor, from the results it was suggests that Mesuaferrin-A, may be an effective preventive and therapeutic approach for patients with inflammatory-related diseases.
2. Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 2005;4:281-6.
3. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008;454:428-35.
4. Nagendra Sastry Y, Anupam B, Gautam S, Reddanna P, Arunasree MK, Dhananjaya BL, et al. Targeting arachidonic acid pathway by natural products for cancer prevention and therapy. Semin Cancer Biol 2016;40â€“41:48-81.
5. Krishna Chaithanya K, Kamalakararao K, Sastry YN, Padal SB, Rajyalakshmi A, Govinda Rao D. Anti-Inflammatory, antioxidant and phytochemical analysis of Mesuaferrea bark extracts. Int J Curr Trends Pharm Res 2015;3:891â€“902.
6. Narender Prasad D, Ganga Rao B, Sambasiva Rao E, Mallikarjuna Rao T, Praneeth VS. Quantification of phytochemical constituents and in vitro antioxidant activity of Mesuaferrea leaves. Asian Pacific J Trop Biomed 2012;56:S539-S542.
7. Pinkesh KT, Irchhaiya R, Jain SK. Evaluation of the anticonvulsant activity of Mesuaferrea Linn. ethanolic flower extract. Int J Pharm Life Sci 2012;3:1507-9.
8. Sircar JC, Schwender CF, Johnson EA. Soy-bean lipoxygenase inhibition by non-steroidal anti-inflammatory drugs. Protaglandins 1983;25:393-6.
9. Reddanna P, Rao MK, Reddy CC. Inhibition of 5-lipoxygenase by vitamin E. FEBS Lett 1985;193:39â€“43.
10. Baylac S, Racine P. Inhibition of 5-lipoxygenase by essential oils and other natural fragrant extracts. Int J Aromather 2003;13:138â€“42.
11. Winter CA, Risley EA, Nuss GW. Carrageenan-induced paw edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962;111:544â€“54.
12. Vinegar R, Scheiber W, Hugo R. Biphasic development of carrageenan edema in rat. J Pharmacol Exp Ther 1969;166:96-103.
13. Beg S, Swain S, Hasan H, Barkat MA, Hussain MS. Systematic review of herbals as potential anti-inflammatory agents: recent advances, current clinical status and future perspectives. Pharmacogn Rev 2011;5:120-37.
14. Reynolds JF, Noakes TD, Schwellnus MP, Windt A, Bowerbank P. Non-steroidal anti-inflammatory drugs fail to enhance healing of acute hamstring injuries treated with physiotherapy. South Afr Med J 1995;85:517â€“22.
15. Kamalakararao K, Krishna Chaithanya K, Gopalakrishnan VK, Zenebe Hagos, Kalayu MA, Patricia PN, et al. Apigenin-7-O-Î’-D-glucuronide methyl ester isolated from Manilkarazapota leaves. Int J Pharm Quality Assurance 2017;8:58-65.
16. Hong J, Bose M, Ju J, Ryu JH, Chen X, Sang S, et al. Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenase and 5-lipooxygenase. Carcinogenesis 2004;25: 1671-9.
17. Cao H, Yu R, Choi Y, Ma ZZ, Zhang H, Xiang W, et al. Discovery of cyclooxygenase inhibitors from medicinal plants used to treat inflammation. Pharmacol Res 2010;61:519â€“24.
18. Han CM, Zhou XY, Cao J, Zhang XY, Chen X. Dihydroxy groups are critical for the anticancer effects. Garcinol Bioorg Chem 2015;60:123-9.
19. Yosie A, Leni M, Habsah M, Hermansyah A, Siti Aisha MR, Jasnizat S. Anti-inflammatory activity of bacteria associated with a marine sponge (Haliclonaamboinensis) via reducing NO production and inhibiting cyclooxygenase-1, cyclooxygenase-2, and secretory phospholipase A2 activities. Asian J Pharm Clin Res 2017;10:95-100.
20. Muralidhar A, Sudhakar Babu K, Ravi Sankar T, Reddanna P, Reddy GV, Latha J. Anti-inflammatory activity of flavonoid fraction isolated from the stem bark of Buteaonosperma (LAM): a mechanism based study. Int J Phytopharmacol 2010;1:124-32.
21. Ishwar Bhat K, Abhishek Kumar. Synthesis and anti-inflammatory activity of some novel 1, 5 benzodiazepine derivatives. Asian J Pharm Clin Res 2016;9:63-6.